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The purpose behind this integrative literature 
review is to investigate the potential for 
recurrence of future ischemic strokes in the 
case of patients experiencing an acute 
ischemic stroke that receive t-PA within the 3 
to 4.5 hour administration window following 
acute onset of symptoms.
This research aims to provide further 
understanding of current ischemic stroke 
research and the future of thrombolytic 
therapy in treating patients experiencing 
acute ischemic stroke. 
One in twenty individuals in the United States 
are killed from stroke every year. Stroke is 
rated the number five cause of death in the 
United States. Cerebrovascular accidents 
(CVAs) are classified as either ischemic or 
hemorrhagic and 87% of strokes are ischemic 
in nature. 
In 1995, the National Institute of Neurological 
Disease and Stroke (NINDS) began a 
revolutionary turning point in the treatment 
and outcomes of ischemic stroke due to the 
development of intravenous recombinant 
tissue plasminogen activator (t-PA). Results 
from the NINDS trial concluded that 
treatment for ischemic stroke can be achieved 
with the use of t-PA, resulting in an improved 
clinical outcome for patients experiencing 
acute ischemic stroke. 
Integrative literature reviews examine the 
topic of choice, critique the topic, and 
synthesize the information reviewed. This 
method is the design of choice because it 
appropriately addresses current research on 
the use of t-PA for prevention of recurrent 
ischemic strokes in patients experiencing an 
acute ischemic stroke in a orderly fashion.
The research is processed among different 
frameworks to see if new information or ideas 
can be discovered.
The conceptual framework used for this 
integrative literature review is based off and 
relative to Ida Jean Orlando’s 1961 Nursing 
Process Discipline Theory. 
The patient experiencing an acute ischemic 
stroke would be the identified problem. It is 
up to the nurse to utilize the nursing process 
(assessment, diagnosis, planning, 
implementation, evaluation) in order to 
produce the best outcomes for the patient. 
The primary intervention addressed for this 
research is t-PA administration. 
The outcome of this integrative literature 
review has shed light on the topic of t-PA 
administration and recurrence of acute 
ischemic stroke, perhaps in not directly 
answering the research question, but with 
potential to explore new routes for further 
research where there may be a gap in 
knowledge. 
After completing the review of literature, only 
one study out of the ten studies meeting the 
inclusion criteria addressed the research 
question. However, the study indicated that 
there was no difference in stroke recurrence 
after t-PA administration post acute ischemic 
stroke. 
Unfortunately, there was lack of evidence 
suggesting that t-PA administration may aid in 
preventing recurrence of stroke because there 
are so few instances that recurrent acute 
ischemic stroke actually happens on more 
than one occasion.
Nursing practice originates to the concept of 
patient education on prevention of 
cardiovascular disease and stroke. The nurse 
educates on how to prevent the occurrence of 
stroke by decreasing risk factors. Educating 
the patient on how to make healthy lifestyle 
choices by monitoring their diet and achieving 
adequate exercise is the foundation of living a 
healthy lifestyle.
Administration of t-PA in the event of an acute 
ischemic stroke significantly improves the 
patient’s prognosis, recovery, and outcomes 
in a single treatment when indicated. It has 
been observed that patients’ ineligibility for 
thrombolytic therapy have poorer recovery 
outcomes and higher incidence of mortality.
To perhaps propose a future research 
question, an interesting topic could 
investigate the incidence of intracranial 
hemorrhage following administration of t-PA 
and observing patient outcomes and 
recovery.
Research Question
Tissue plasminogen activator (t-PA) is 
considered the gold standard for treatment of 
acute ischemic stroke. When t-PA is 
administered within 3 to 4.5 hours of 
symptom onset, it is observed to reduce the 
compromising long-term effects significantly.
Does the use of t-PA aid in preventing 
recurrence of future ischemic strokes in 
patients actively experiencing an acute 
ischemic stroke?
